Old Web
English
Sign In
Acemap
>
authorDetail
>
S Jones
S Jones
Takeda Pharmaceutical Company
Vedolizumab
Medicine
Internal medicine
Crohn's disease
Diabetes mellitus
4
Papers
81
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Endoscopic, radiologic, and histologic healing with vedolizumab in patients with active Crohn’s disease
2019
Gastroenterology
Silvio Danese
William J. Sandborn
Jean-Frederic Colombel
Severine Vermeire
Sarah C. Glover
Jordi Rimola
Jenifer Siegelman
S Jones
Jeffrey D Bornstein
Brian G. Feagan
Show All
Source
Cite
Save
Citations (69)
P376 Effects of IV vedolizumab on health-related quality of life and work productivity in patients with Crohn’s disease: results from the Phase 3b VERSIFY trial
2019
Journal of Crohns & Colitis
S. Danese
S Adsul
D Lindner
S Jones
Haridarshan Patel
J.-F. Colombel
Show All
Source
Cite
Save
Citations (1)
PTH-091 Effects of vedolizumab on HRQoL and work productivity in Crohn’s disease: results from versify
2019
Gut
Silvio Danese
Shashi Adsul
Dirk Lindner
S Jones
Haridarshan Patel
J.-F. Colombel
Show All
Source
Cite
Save
Citations (0)
OP023 A phase 3b open-label multicentre study (VERSIFY) of the efficacy of vedolizumab on endoscopic healing in moderately to severely active Crohn’s disease (CD)
2018
Journal of Crohns & Colitis
S. Danese
Brian G. Feagan
William J. Sandborn
J.-F. Colombel
Severine Vermeire
S Jones
K Brennan
Jeffrey Bornstein
Show All
Source
Cite
Save
Citations (11)
1
map